Titre:
  • Putative contribution of CD56 positive cells in cetuximab treatment efficacy in first-line metastatic colorectal cancer patients.
Auteur:Marechal, Raphaël; De Schutter, Jef; Nagy, Nathalie; Demetter, Pieter; Lemmers, Arnaud; Devière, Jacques; Salmon, Isabelle; Tejpar, Sabine; Van Laethem, Jean-Luc
Informations sur la publication:BMC cancer, 10, page (340)
Statut de publication:Publié, 2010
Sujet CREF:Anatomopathologie
Médecine pathologie humaine
MeSH keywords:Adenocarcinoma -- drug therapy -- metabolism -- secondary
Adult
Aged
Antibodies, Monoclonal -- therapeutic use
Antibody-Dependent Cell Cytotoxicity
Antigens, CD56 -- metabolism
Antineoplastic Agents -- therapeutic use
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Colorectal Neoplasms -- drug therapy -- metabolism -- pathology
Female
Flow Cytometry
Humans
Immunoenzyme Techniques
Liver Neoplasms -- drug therapy -- metabolism -- secondary
Lung Neoplasms -- drug therapy -- metabolism -- secondary
Lymphatic Metastasis
Middle Aged
Mutation -- genetics
Neoplasm Staging
Polymerase Chain Reaction
Prospective Studies
Proto-Oncogene Proteins -- genetics
Receptor, Epidermal Growth Factor -- antagonists & inhibitors -- metabolism
Retrospective Studies
Survival Rate
Treatment Outcome
ras Proteins -- genetics
Note générale:Journal Article
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1471-2407
info:doi/10.1186/1471-2407-10-340
info:pii/1471-2407-10-340
info:scp/77954054889
info:pmid/20591136
PMC2912265